BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34340261)

  • 1. The management of Castleman disease.
    Lomas OC; Streetly M; Pratt G; Cavet J; Royston D; Schey S; Ramasamy K;
    Br J Haematol; 2021 Nov; 195(3):328-337. PubMed ID: 34340261
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-associated multicentric Castleman disease.
    Reddy D; Mitsuyasu R
    Curr Opin Oncol; 2011 Sep; 23(5):475-81. PubMed ID: 21760504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma herpesvirus-associated Castleman's disease with POEMS syndrome.
    Kim DE; Kim HJ; Kim YA; Lee KW
    Muscle Nerve; 2000 Mar; 23(3):436-9. PubMed ID: 10679723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Castleman disease.
    Dispenzieri A; Fajgenbaum DC
    Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated multicentric Castleman disease.
    Oksenhendler E
    Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Castleman Disease.
    Szalat R; Munshi NC
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus-8-positive microvenular hemangioma in POEMS syndrome.
    Hudnall SD; Chen T; Brown K; Angel T; Schwartz MR; Tyring SK
    Arch Pathol Lab Med; 2003 Aug; 127(8):1034-6. PubMed ID: 12873182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I treat HHV8/KSHV-related diseases in posttransplant patients.
    Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
    Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castleman's disease--a two compartment model of HHV8 infection.
    Schulte KM; Talat N
    Nat Rev Clin Oncol; 2010 Sep; 7(9):533-43. PubMed ID: 20603649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
    Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
    Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
    [No Abstract]   [Full Text] [Related]  

  • 13. Castleman disease.
    Carbone A; Borok M; Damania B; Gloghini A; Polizzotto MN; Jayanthan RK; Fajgenbaum DC; Bower M
    Nat Rev Dis Primers; 2021 Nov; 7(1):84. PubMed ID: 34824298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.
    Fajgenbaum DC
    Blood; 2018 Nov; 132(22):2323-2330. PubMed ID: 30487129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
    Shivane A; Pearce A; Khatib N; Smith MEF
    Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.
    Powles T; Stebbing J; Montoto S; Nelson M; Gazzard B; Orkin C; Webb A; Bower M
    Blood; 2007 Dec; 110(12):4132-3. PubMed ID: 18024800
    [No Abstract]   [Full Text] [Related]  

  • 17. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
    Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
    [No Abstract]   [Full Text] [Related]  

  • 18. POEMS syndrome: are current diagnostic criteria too exclusive?
    Charli-Joseph Y; Fernández-Sánchez M; Saeb-Lima M; Orozco-Topete R
    J Am Acad Dermatol; 2011 Aug; 65(2):415-417. PubMed ID: 21501892
    [No Abstract]   [Full Text] [Related]  

  • 19. Castleman disease and TAFRO syndrome.
    Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
    Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.